Equities.com invites you to watch Legalized: Making Sense of the Marijuana Green Rush our ground-breaking roundtable discussion on the impact of recreational marijuana's legalization in the United States. Our amazing panel of leading experts offer incredible insights from their perspectives of the regulatory, legislative, medical and business aspects of the industry. Click here to watch now.
The marijuana industry, which is chock full of young companies with plans to capitalize the nascent business, has yet another new player. The yellow pages as we grew up with may be a bit of an artifact at this point, but a couple nano-caps have a vision of bringing a portion of it to the digital age with an accompanying scent of pot.
Kuboo, Inc. (SGTB) , which does business as Safe Communications, Inc., and Safe’s 80-percent owned subsidiary Northsight Capital ($NCAP) on Tuesday said that they have signed a non-binding letter of intent to acquire about 7,000 domains enveloped in the marijuana, cannabis and hemp arena. Currently, Scottsdale, Arizona-based Kuboo runs a 3D virtual world website with the mantra “Where Kids Rule,” that’s full of games where kids can play, learn, chat and more with their friends in a controlled, safe digital environment.
It’s fair to say that the new initiative is a stark diversification from kuboo.com.
The proposed plan entails Northsight changing its name to The Marijuana Advertising Group and taking control of the stack of aforementioned domains, including, but certainly not limited to MedicalMarijuanaDispensaryWashington.com, WashingtonMarijuanaDirectory.com, or BestMarijuanaWashington.com. Other domains are fashioned the same way to hit keywords, with about 90 to 120 domains for each state.
The seller of the domains was not named in the announcement, but they will be getting a good chunk of Northsight Capital as payment for the assets, receiving about 80 percent of The Marijuana Advertising Group. Northsight currently has 12.5 million shares outstanding, according to QuoteMedia. Safe Communications will keep about 10 percent and plans to spin off its stake to shareholders of NCAP (no word was given if a ticker change will accompany the name change).
Amongst other conditions, the deal is contingent upon Northsight raising at least $750,000 to build-out the new website.
“The proposed business model will be that of Yellow Pages for the marijuana industry. The domains consist of Cannabis, Marijuana, Medical Marijuana, Hemp, Pot, Weed, Dispensaries, Directory's, Growers, Suppliers, Distributors, Market & Supermarkets, Stores, Shops, Shack, Hut, Bakery, Edibles, Snacks, Medical Marijuana Physicians, etc.,” said the companies in a joint (no pun intended) statement.
Can they turn this into something successful? That answer is a firm “maybe” at this stage, as the contract stipulations need to be met just for starters and there's a long IT road ahead to capture market share. $750,000 is enough to get the ball rolling, but they will need substantially more capital going forward.
It’s presumable that all of these domains will redirect to one website, which could lead to quite a bit of revenue-generating traffic (under the assumption that ads are going to be a sales driver) as more and more states legalize marijuana in one form or another. There are already 20 states and the District of Columbia as initial targets, meaning that the traffic population is there, but rivals are already on the move.
Another nano-cap, Mediswipe Inc. (MWIP) has previously launched MarijuanaDoctors.com, an online search and booking platform to connect qualified patients and medical marijuana doctors. Investors certainly seemed optimistic about the transaction and plan. Penny stocks are known for their incredible volatility, and that was exemplified by NCAP surging a whopping 552.5 percent in Tuesday action following the news from 40 cents to $2.61, albeit on volume of only 72,930. Shares of SGTB also rose, advancing 25.1 percent to 15 cents.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer